CD4 and infection: We also note that our in vitro latency model employs the protease inhibitor saquinavir immediately after memory CD4+ T cells are exposed to the replication-competent virus; this limits the infection to a single round and also limits the accumulation of inactivating mutations or deletions that may be observed in the ex vivo samples, which can influence the observed frequency of HIV latency reversal.